Lethal sepsis and malignant transformation in severe congenital neutropenia: report from the Italian Neutropenia Registry. - Suppr | 超能文献

Lethal sepsis and malignant transformation in severe congenital neutropenia: report from the Italian Neutropenia Registry.

作者信息

Fioredda Francesca, Calvillo Michaela, Lanciotti Marina, Cefalo Maria Giuseppina, Tucci Fabio, Farruggia Piero, Casazza Gabriella, Martire Baldassarre, Bonanomi Sonia, Notarangelo Luciadora, Barone Angelica, Palazzi Giovanni, Davitto Mirella, Barella Susanna, Cardinale Fabio, Mastrodicasa Elena, Cugno Chiara, Russo Giovanna, Caviglia Ilaria, Caruso Silvia, Castagnola Elio, Dufour Carlo

机构信息

Unit of Haematology, Giannina Gaslini Children's Hospital, Genova.

出版信息

Pediatr Blood Cancer. 2015 Jun;62(6):1110-2. doi: 10.1002/pbc.25401. Epub 2015 Jan 25.

DOI:10.1002/pbc.25401

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Lethal sepsis and malignant transformation in severe congenital neutropenia: report from the Italian Neutropenia Registry.

Pediatr Blood Cancer. 2015 Jun;62(6):1110-2. doi: 10.1002/pbc.25401. Epub 2015 Jan 25.

2

Lymphadenopathy as the primary manifestation of malignant transformation in two patients with severe congenital neutropenia.两名严重先天性中性粒细胞减少症患者出现淋巴结病作为恶性转化的主要表现。

Pediatr Blood Cancer. 2008 May;50(5):1072-5. doi: 10.1002/pbc.21485.

3

Impaired myelopoiesis in congenital neutropenia: insights into clonal and malignant hematopoiesis.先天性中性粒细胞减少症中的骨髓生成受损：对克隆性和恶性造血的深入了解。

Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):514-520. doi: 10.1182/hematology.2021000286.

4

Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy.G-CSF 治疗维持下严重先天性中性粒细胞减少症患者白血病的稳定长期风险。

Br J Haematol. 2010 Jul;150(2):196-9. doi: 10.1111/j.1365-2141.2010.08216.x. Epub 2010 Apr 29.

5

[Hematological malignancies in congenital neutropenia].[先天性中性粒细胞减少症中的血液系统恶性肿瘤]

Rinsho Ketsueki. 2010 Jul;51(7):553-8.

6

Prevention and control of infections in patients with severe congenital neutropenia; a follow up study.严重先天性中性粒细胞减少症患者感染的预防与控制；一项随访研究。

Iran J Allergy Asthma Immunol. 2012 Mar;11(1):51-6.

7

Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.先天性中性粒细胞减少症患者骨髓增生异常综合征、白血病及感染相关死亡的危险因素分析。法国严重慢性中性粒细胞减少症研究组的经验。

Haematologica. 2005 Jan;90(1):45-53.

8

Screening for G-CSF receptor mutations in patients with secondary myeloid or lymphoid transformation of severe congenital neutropenia. A report from the French neutropenia register.严重先天性中性粒细胞减少症继发髓系或淋巴系转化患者中粒细胞集落刺激因子受体突变的筛查。来自法国中性粒细胞减少症登记处的报告。

Leukemia. 2004 Sep;18(9):1553-5. doi: 10.1038/sj.leu.2403431.

9

Chromosomal aberrations in congenital bone marrow failure disorders--an early indicator for leukemogenesis?先天性骨髓衰竭性疾病中的染色体畸变——白血病发生的早期指标？

Ann Hematol. 2007 Oct;86(10):733-9. doi: 10.1007/s00277-007-0337-z. Epub 2007 Jul 25.

10

Malignant myeloid transformation in congenital forms of neutropenia.先天性中性粒细胞减少症的恶性髓系转化

Isr Med Assoc J. 2002 Nov;4(11):1011-4.

引用本文的文献

1

Autoimmune Neutropenias: Update on Clinical and Biological Features in Children and Adults.自身免疫性中性粒细胞减少症：儿童和成人临床及生物学特征的最新进展

Hemasphere. 2022 Dec 19;7(1):e814. doi: 10.1097/HS9.0000000000000814. eCollection 2023 Jan.

2

Description of an Mutation in a Girl with Severe Congenital Neutropenia: A Paradigm of Targeted Genetic Screening Based on Clinical Findings.一名患有严重先天性中性粒细胞减少症女孩的突变描述：基于临床发现的靶向基因筛查范例

J Pediatr Genet. 2019 Mar;8(1):33-37. doi: 10.1055/s-0038-1670724. Epub 2018 Sep 15.

3

Neutropenia in the age of genetic testing: Advances and challenges.基因检测时代的中性粒细胞减少症：进展与挑战。

Am J Hematol. 2019 Mar;94(3):384-393. doi: 10.1002/ajh.25374. Epub 2019 Jan 8.

4

[Advances in research on childhood neutropenia].[儿童中性粒细胞减少症的研究进展]

Zhongguo Dang Dai Er Ke Za Zhi. 2017 Apr;19(4):484-489. doi: 10.7499/j.issn.1008-8830.2017.04.023.